India
· Delayed Price · Currency is INR Strides Pharma Science Company Description
Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally.
It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams.
It also develops branded generics products for the treatment of chronic therapies, including women’s health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business.
The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018.
Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.
| Country | India |
| Founded | 1990 |
| Industry | Pharmaceutical Preparations |
| Employees | 3,065 |
| CEO | Badree Komandur |
Contact Details
Address: Strides House Bengaluru, 560076 India | |
| Phone | 91 80 6784 0000 |
| Website | strides.com |
Stock Details
| Ticker Symbol | 532531 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Badree Komandur | Chief Executive Officer |
| Vikesh Kumar | Chief Financial Officer |
| P. V. Ramaraju | Chief Operating Officer |
| Vikesh Kumar | Head of Investor Relations |